Suppr超能文献

一种 SARS-CoV-2 NSP7 同系物的 T reg 表位抑制 CD4+和 CD8+T 细胞记忆应答。

A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses.

机构信息

EpiVax, Inc., Providence, RI, United States.

Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States.

出版信息

Front Immunol. 2023 Nov 24;14:1290688. doi: 10.3389/fimmu.2023.1290688. eCollection 2023.

Abstract

Pathogens escape host defenses by T-cell epitope mutation or deletion (immune escape) and by simulating the appearance of human T cell epitopes (immune camouflage). We identified a highly conserved, human-like T cell epitope in non-structural protein 7 (NSP7) of SARS-CoV-2, RNA-dependent RNA polymerase (RdRp) hetero-tetramer complex. Remarkably, this T cell epitope has significant homology to a T regulatory cell epitope (Tregitope) previously identified in the Fc region of human immunoglobulin G (IgG) (Tregitope 289). We hypothesized that the SARS-CoV-2 NSP7 epitope (NSP7-289) may induce suppressive responses by engaging and activating pre-existing regulatory T cells. We therefore compared NSP7-289 and IgG Tregitopes (289 and 289z, a shorter version of 289 that isolates the shared NSP7 epitope) . Tregitope peptides 289, 289z and NSP7-289 bound to multiple HLA-DRB1 alleles and suppressed CD4+ and CD8+ T cell memory responses. Identification and validation of SARS-CoV-2 NSP7-289 provides further evidence of immune camouflage and suggests that pathogens can use human-like epitopes to evade immune response and potentially enhance host tolerance. Further exploration of the role of cross-conserved Tregs in human immune responses to pathogens such as SARS-CoV-2 is warranted.

摘要

病原体通过 T 细胞表位突变或缺失(免疫逃逸)以及模拟人类 T 细胞表位的外观(免疫伪装)来逃避宿主防御。我们在 SARS-CoV-2 的非结构蛋白 7(NSP7)、RNA 依赖性 RNA 聚合酶(RdRp)异源四聚体复合物中鉴定出一个高度保守的、类似人类的 T 细胞表位。值得注意的是,这个 T 细胞表位与先前在人免疫球蛋白 G(IgG)Fc 区域鉴定出的 T 调节细胞表位(Tregitope)具有显著的同源性(Tregitope 289)。我们假设,SARS-CoV-2 的 NSP7 表位(NSP7-289)可能通过与预先存在的调节性 T 细胞结合和激活来诱导抑制性反应。因此,我们比较了 NSP7-289 和 IgG Tregitope(289 和 289z,289 的较短版本,分离出共同的 NSP7 表位)。Tregitope 肽 289、289z 和 NSP7-289 与多个 HLA-DRB1 等位基因结合,并抑制 CD4+和 CD8+T 细胞记忆反应。SARS-CoV-2 NSP7-289 的鉴定和验证进一步证明了免疫伪装的存在,并表明病原体可以利用类似人类的表位来逃避免疫反应,并可能增强宿主的耐受性。进一步探索交叉保守的 Tregs 在人类对 SARS-CoV-2 等病原体免疫反应中的作用是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0c/10731459/09eb23842a0f/fimmu-14-1290688-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验